Menko-Jan de Boer

Showing 1-3 of 3 articles

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

Heestermans A, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, van Houwelingen K, Koopmans P, Hamm C, Zijlstra F, ten Berg J, van’t Hof A

August 30, 2011 | 10.4244/EIJV7I4A73

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

de Boer M, Hoorntje J, Gosselink A, Suryapranata H, van’t Hof A

May 25, 2010

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

Dambrink J, Debrauwere J, van’t Hof A, Ottervanger J, Gosselink M, Hoorntje J, de Boer M, Suryapranata H

April 12, 2010

1

Latest news

EAPCI consensus document on myocardial revascularisation failure; antegrade vs retrograde approach in CTO PCI and more…

December 4, 2020

Read the LEMON study

December 1, 2020

Repeat revascularisation: “An ounce of prevention is worth a pound of cure”

December 4, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

An obituary for Professor Tony Gershlick 1951-2020

December 1, 2020

This Week's JAA's: Balloon-based techniques for calcific CAD...

December 1, 2020

Valvular disease